disclosures electronic fetal monitoring the good the bad
play

Disclosures Electronic Fetal Monitoring The Good, the Bad and the - PowerPoint PPT Presentation

6/14/2019 Disclosures Electronic Fetal Monitoring The Good, the Bad and the Ugly I have nothing to disclose. Jeanne S. Sheffield, MD Maternal-Fetal Medicine Johns Hopkins Medicine The History of Fetal Monitoring The History of Fetal


  1. 6/14/2019 Disclosures Electronic Fetal Monitoring The Good, the Bad and the Ugly I have nothing to disclose. Jeanne S. Sheffield, MD Maternal-Fetal Medicine Johns Hopkins Medicine The History of Fetal Monitoring The History of Fetal Monitoring • 1600s Marsac first detected a fetal heart • 1917 fetoscope developed by David Hillis rate • Intermittent auscultation guidance • 1818 Mayor and Kergaradec auscultated – 1968 24,863 IA labors reviewed fetal heart sounds using an ear to the • Not a reliable indicator of fetal distress maternal abdomen • Used for over 40 years before first RCT • Multiple attempts at capturing the fetal – Used for detection of viability ECG from 1906 • 1833 Kennedy published guidelines for – 1958 Hon able to capture continuous fetal fetal distress based on fetal auscultation ECG and by the 1960s EFM systems were in • 1893 Von Winkel criteria for fetal distress commercial use 1

  2. 6/14/2019 The History of Fetal Monitoring Limitations of EFM • 1972 Hon and Hess developed the fetal • While it is the most commonly performed scalp electrode obstetric procedure….. • By 1975, ~ 20% of labors – Failed to decrease rates of cerebral palsy and neurologic injury were monitored by EFM – No overall decrease in perinatal death • It took over 10 years after EFM was being – Higher operative delivery used consistently before the first RCT was • Medicolegal issues performed. • Now over 85% of deliveries in the United States are monitored using EFM Fetal Heart Rate Monitoring Electronic Fetal Monitoring Frequency • External monitoring • EFM versus intermittent auscultation – Ultrasound doppler principle – Term, low risk… • No meconium staining, intrapartum bleeding, • Internal (Direct) monitoring abnormal fetal test results, no risk of fetal – Bipolar spiral electrode is attached directly to academia developing, maternal conditions that the fetus might affect fetal well-being and no oxytocin induction or augmentation – Fetal cardiac signal is amplified : the R-wave voltage is most reliably detected. Time between R waves is calculated and seen as beat-to-beat variability 2

  3. 6/14/2019 Intermittent Auscultation Standardization of EFM Nomenclature • FHR assessment every 30 minutes in the • NICHD 1997 Fetal Monitoring Research active phase of the first stage of labor and Planning Workshop every 15 minutes in the second stage – Standardized, unambiguous definitions • If risk factors develop, moves to every 15 – Research recommendations, especially to address the poor specificity to predict fetal minutes and every 5 minutes compromise • NICHD, ACOG and SMFM 2008 Workshop – Update the definitions for CTG patterns – Research prioroities Let’s All Speak the Same Language Improving Patient Safety and Outcomes Obstet Gynecol 2008 • Assumptions – Visual interpretation (but left room for AI) – Direct fetal electrode OR external Doppler device using autocorrelation technique – Features categorized as baseline, periodic (with uterine contractions) or episodic (not associated with contractions) 3

  4. 6/14/2019 Obstet Gynecol 2008 • Assumptions Obstet Gynecol 2008 – Patterns categorized as abrupt or gradual Uterine contractions: number of contractions in a 10 – No distinction made between short and long term minute window averaged over 30 minutes variability - Normal: ≤5 contractions in 10 minutes – FHR tracings should be evaluated in the context - Tachysystole: >5 contractions in a 10 minute of clinical factors e.g. EGA, maternal physiologic window state, fetal conditions - Hyperstimulation and hypercontractility were – FHR patterns evolve over time abandoned Fetal Heart Rate Patterns • Baseline: mean FHR rounded to increments of 5 bpm during a 10 minute window, excluding accelerations and decelerations and marked variability (>25bpm) – Bradycardia <110 bpm – Tachycardia >160 bpm • Baseline FHR Variability: 10 minute window – Absent – Minimal: amplitude ≥ 5 bpm – Moderate: amplitude 6-25 bpm – Marked: amplitude > 25 bpm 4

  5. 6/14/2019 Fetal Heart Rate Variability Fetal Heart Rate Patterns • Acceleration: abrupt (onset to peak <30 seconds) increase in FHR – Peak must be ≥ 15 bpm, lasting ≥15 seconds • Before 32 weeks, peak ≥ 10 bpm and duration ≥ 10 seconds – Prolonged: ≥ 2 minutes but < 10 minutes – Baseline change: ≥ 10 minutes Marked Variability or Saltatory LTV ≥ 25 bpm Causes – fetal activity, compensatory response to hypoxemia Fetal Heart Rate Patterns • Decelerations – Prolonged: decrease in FHR ≥ 15 bpm, lasting ≥ 2 minutes but <10 minutes – Sinusoidal: Visually apparent, smooth sine wave-like undulating pattern with a cycle frequency of 3-5/minute, persisting ≥ 20 minutes 5

  6. 6/14/2019 Fetal Heart Rate Categorization Fetal Heart Rate Patterns • Three-tier system • Decelerations – At a specific point in time – the FHT may – Recurrent if occur with ≥ 50% of uterine contractions in move back and forth over time any 20 minute window – Limited management discussion – Intermittent if occur <50% of uterine contractions in any – Cannot predict cerebral palsy 20 minute window – Unknown the predictive value of grading systems that utilize the depth of the deceleration NORMAL Strongly predictive of normal acid-base status Other Important Notes… • FHTs need to be interpreted in the clinical context INDETERMINATE • FHR accelerations (spontaneous or induced) reliably predicts the absence of fetal metabolic acidemia – The absence does NOT reliably predict acidemia however.. • Moderate FHR variability also predicts the ABNORMAL absence of fetal metabolic acidemia – Minimal, absent or marked unclear Predictive of abnormal fetal acid-base status 6

  7. 6/14/2019 Fetal Pulse Oximetry • 2000 FDA approved a fetal pulse oximetry 5341 nulliparous women in early labor were randomized to open system to use as an adjunct to EFM or masked fetal pulse oximetry. – Sensor was placed through the cervix alongside the fetal face to measure fetal oxygen saturation. – Early studies showed some correlation between fetal metabolic acidosis and fetal saturation readings in the setting of a non- reassuring FHT. 2014 Cochrane Collaboration ST Segment Analysis (STAN) • Fetal Pulse Oximetry did not reduce the • Approved by the FDA in 2005 but used in overall Cesarean section rate Europe for two decades • A better method than pulse oximetry is • Standard cardiotocography (CTG) with required to enhance the overall evaluation concurrent assessment of the fetal ECG. of fetal well-being in labour. – Normal ST waveform is horizontal or upward sloping – Normal T-wave has a constant amplitude – Changes in the waveforms may reflects fetal hypoxia 7

  8. 6/14/2019 11,108 term women in early to active labor with a singleton 2015 gestation were randomized to open or masked ECG ST-Segment No difference in analysis Cesarean delivery or operative delivery The Pros and Cons of EFM ST Segment Analysis (STAN) • Screening test with poor positive • 2015 Cochrane Review Fetal ECG for predictive value, esp. in low risk women Fetal Monitoring During Labor • No randomized clinical trials other than a – Over 27,000 women from 7 trials comparison to IA • No difference in Cesarean rate, severe fetal – Increased Cesarean delivery rates acidosis or neonatal encephalopathy, no decrease in low 5 minute Apgar score – Increased operative delivery rates • Fewer fetal scalp samples and operative vaginal – Did not reduce perinatal mortality deliveries (marginal) – Did not reduce the risk of cerebral palsy • Several studies since this time have had – Did decrease risk of neonatal seizures similar findings. • High intra- and intervariability 8

  9. 6/14/2019 EFM and Cerebral Palsy • EFM does not predict cerebral palsy and we should not expect it to – PPV of a non-reassuring pattern of a singleton infant >2500gm is 0.14% (1000 abnormal FHTs, 1-2 will develop cerebral palsy) – False positive rate of >99% Nelson et al NEJM 1996 9

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend